» Articles » PMID: 24797146

Neuronal Expression of the Intermediate Conductance Calcium-activated Potassium Channel KCa3.1 in the Mammalian Central Nervous System

Overview
Journal Pflugers Arch
Specialty Physiology
Date 2014 May 7
PMID 24797146
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The expression pattern and functional roles for calcium-activated potassium channels of the KCa2.x family and KCa1.1 have been extensively examined in central neurons. Recent work indicates that intermediate conductance calcium-activated potassium channels (KCa3.1) are also expressed in central neurons of the cerebellum and spinal cord. The current study used immunocytochemistry and GFP linked to KCNN4 promoter activity in a transgenic mouse to determine the expression pattern of KCa3.1 channels in rat or mouse neocortex, hippocampus, thalamus, and cerebellum. KCa3.1 immunolabel and GFP expression were closely matched and detected in both excitatory and inhibitory cells of all regions examined. KCa3.1 immunolabel was localized primarily to the somatic region of excitatory cells in cortical structures but at the soma and over longer segments of dendrites of cells in deep cerebellar nuclei. More extensive labeling was apparent for inhibitory cells at the somatic and dendritic level with no detectable label associated with axon tracts or regions of intense synaptic innervation. The data indicate that KCa3.1 channels are expressed in the CNS with a differential pattern of distribution between cells, suggesting important functional roles for these calcium-activated potassium channels in regulating the excitability of central neurons.

Citing Articles

Potassium KCa3.1 channel overexpression deteriorates functionality and availability of channels at the outer cellular membrane.

Bal N, Oblasov I, Ierusalimsky V, Shvadchenko A, Fortygina P, Idzhilova O Sci Rep. 2025; 15(1):4928.

PMID: 39929947 PMC: 11811289. DOI: 10.1038/s41598-025-89097-8.


A single coiled-coil domain mutation in hIKCa channel subunits disrupts preferential formation of heteromeric hSK1:hIKCa channels.

Charlick J, Bozadzhieva D, Butler A, Wilkinson K, Marrion N Eur J Neurosci. 2023; 59(1):3-16.

PMID: 38018635 PMC: 10952195. DOI: 10.1111/ejn.16189.


Role of SNARE Proteins in the Insertion of KCa3.1 in the Plasma Membrane of a Polarized Epithelium.

Farquhar R, Cheung T, Logue M, McDonald F, Devor D, Hamilton K Front Physiol. 2022; 13:905834.

PMID: 35832483 PMC: 9271999. DOI: 10.3389/fphys.2022.905834.


Corticotropin Releasing Factor Mediates K3.1 Inhibition, Hyperexcitability, and Seizures in Acquired Epilepsy.

Tiwari M, Mohan S, Biala Y, Shor O, Benninger F, Yaari Y J Neurosci. 2022; 42(30):5843-5859.

PMID: 35732494 PMC: 9337610. DOI: 10.1523/JNEUROSCI.2475-21.2022.


Regulation of Hippocampal Gamma Oscillations by Modulation of Intrinsic Neuronal Excitability.

Klemz A, Wildner F, Tutuncu E, Gerevich Z Front Neural Circuits. 2022; 15:778022.

PMID: 35177966 PMC: 8845518. DOI: 10.3389/fncir.2021.778022.


References
1.
Wulff H, Castle N . Therapeutic potential of KCa3.1 blockers: recent advances and promising trends. Expert Rev Clin Pharmacol. 2011; 3(3):385-96. PMC: 3347644. DOI: 10.1586/ecp.10.11. View

2.
Murthy S, Teodorescu G, Nijholt I, Dolga A, Grissmer S, Spiess J . Identification and characterization of a novel, shorter isoform of the small conductance Ca2+ -activated K+ channel SK2. J Neurochem. 2008; 106(6):2312-21. DOI: 10.1111/j.1471-4159.2008.05557.x. View

3.
Allen D, Bond C, Lujan R, Ballesteros-Merino C, Lin M, Wang K . The SK2-long isoform directs synaptic localization and function of SK2-containing channels. Nat Neurosci. 2011; 14(6):744-9. PMC: 3417338. DOI: 10.1038/nn.2832. View

4.
Furness J, Robbins H, Selmer I, Hunne B, Chen M, Hicks G . Expression of intermediate conductance potassium channel immunoreactivity in neurons and epithelial cells of the rat gastrointestinal tract. Cell Tissue Res. 2003; 314(2):179-89. DOI: 10.1007/s00441-003-0808-z. View

5.
Wang J, Sarov M, Rientjes J, Fu J, Hollak H, Kranz H . An improved recombineering approach by adding RecA to lambda Red recombination. Mol Biotechnol. 2005; 32(1):43-53. DOI: 10.1385/mb:32:1:043. View